Received May 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Her husband is now diagnosed with myocarditis too; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MYOCARDITIS (Her husband is now diagnosed with myocarditis too) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. In 2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (Her husband is now diagnosed with myocarditis too) (seriousness criterion medically significant). At the time of the report, MYOCARDITIS (Her husband is now diagnosed with myocarditis too) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) was unknown. No vaccines within the past 4 weeks prior to the Moderna vaccine was reported. No concomitant medications were reported. The reporter inquired about methods for removing the COVID spike protein from the body of someone who had received the Moderna COVID vaccine. The reporter stated that the patient had been diagnosed with myocarditis despite never having contracted COVID. It was reported that for some people, the spike protein naturally dissipates, but for others, it remains and causes ongoing health issues. She reported that doctors had not devised a treatment plan, and she criticized claims that myocarditis primarily affects men aged 19 to 30, asserting that individuals up to the age of 80 had reported similar issues. She sought answers regarding the removal of the spike protein. She confirmed that neither her daughter nor son-in-law had experienced any other side effects. She reported that Moderna had known that myocarditis could result from the vaccine but failed to disclose it properly. She mentioned clinical trials she saw on TV, saying that myocarditis had been documented but was reportedly considered a temporary issue in young people. The reporter reiterated that Moderna had known that myocarditis would result from it. The reporter questioned whether the company had a plan to treat vaccine-induced myocarditis, and she also found it strange that both her daughter and her husband had developed the condition. It is unknown if the patient experienced any additional symptoms or events. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2025-786196 (E2B Linked Report).; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-786196:same reporter different patient